Intra-arterial injection of dissolved flunitrazepam tablets.
Intra-arterial application of dissolved tablets is associated with a high risk of tissue necrosis. An early active vasodilatating and recanalising treatment is necessary. We present the case of 21-year-old female who applied three dissolved Flunitrazepam tablets into the ulnar artery and was successfully treated with prostaglandin E1 and recombinant tissue plasminogen activator.
Pratikto
T H
TH
Department of Angiology, University of Essen, Germany.
Strubel
G
G
Biro
F
F
Kröger
K
K
D000328:Adult; D000527:Alprostadil / Q000008:administration & dosage; D000792:Angiography / Q000187:drug effects; D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D005385:Fingers / Q000098:blood supply; D005445:Flunitrazepam / Q000008:administration & dosage / Q000009:adverse effects*; D006225:Hand / Q000098:blood supply*; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D007269:Injections, Intra-Arterial; D007511:Ischemia / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000188:drug therapy; D012995:Solubility; D019966:Substance-Related Disorders / Q000150:complications*; D013607:Tablets; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage; D017535:Ulnar Artery / Q000000981:diagnostic imaging / Q000187:drug effects; D014665:Vasodilator Agents / Q000008:administration & dosage
D014151:Anti-Anxiety Agents; D013607:Tablets; D014665:Vasodilator Agents; D005445:Flunitrazepam; D006493:Heparin; D010959:Tissue Plasminogen Activator; D000527:Alprostadil